Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Docusign Inc (DOCU) vs FMC Corp (FMC) Price & Performance

Docusign IncTrade

Price performance (Past 24H)

Key statistics

Docusign Inc vs FMC Corp — how do they compare? Docusign Inc trades at $59.42 (market cap $11.33B), while FMC Corp trades at $10.48 (market cap $1.30B). The key difference: Docusign Inc is far larger — about 8.7× FMC Corp's market cap, and FMC Corp pays a 3.07% dividend while Docusign Inc pays none. Which is the better fit depends on your goals.

DOCUFMC
Market Cap
$11.33B$1.30B
Sector
TechnologyBasic Materials
52-Week High
$85.01$40.69
52-Week Low
$41.75$10.01
Enterprise Value
$10.70B$5.11B
Dividend Yield
3.07%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Docusign Inc

DOCU trades at $57.82, down 3.05% today, with a bullish technical signal from moving averages but overbought RSI readings. The company reported strong earnings beats in recent quarters, with Q1 2026 EPS of $1.09 exceeding the $0.994 estimate. Revenue growth remains steady, reaching $2.98B in 2025, while profitability improved significantly with a net income margin of 35.87%. Recent news highlights institutional trading activity and positive analyst coverage on growth prospects.

The outlook for DOCU is mixed; fundamentals show robust revenue growth and expanding margins, but valuation multiples like a P/E of 38.53 suggest premium pricing. Key risks include competitive pressures in e-signature software and reliance on subscription revenue. Analyst consensus is cautious with a hold-heavy rating, though the $55.40 price target implies limited upside from current levels.

FMC Corp

FMC Corporation (FMC) trades at $10.24, down 2.1% today, reflecting ongoing investor concerns despite recent earnings beats. The stock shows a bearish technical signal with key support at $10 and resistance at $11. Fundamentally, the company faces significant challenges with a net income margin of -84.83% and negative ROE of -91.47% for 2025, though valuation ratios like P/S of 0.4 and P/B of 0.8 appear attractive. Recent developments include a $400 million minority investment from Tessenderlo Group and regulatory submission for new herbicide technology.

The outlook remains cautious due to persistent profitability issues and revenue declines, with 2025 revenue dropping to $3.47B from $4.2B in 2024. While analyst consensus is mixed with a $11.60 price target suggesting modest upside, high debt levels and competitive pressures pose substantial risks. The company's focus on debt reduction through asset sales and external investments provides some stability, but turnaround execution is critical for sustained recovery.

Returns comparison

Trailing returns across standard periods

About Docusign Inc

DocuSign offers the Agreement Cloud, a broad cloud-based software suite that enables users to automate the agreement process and provide legally binding e-signatures from nearly any device. The company was founded in 2003 and completed its IPO in May 2018.

Read more on DOCU

About FMC Corp

FMC is a pure-play crop chemical company. The company has diversified its sales to create a balanced crop chemical portfolio across geographies and crop exposure. Through acquisitions, FMC is now one of the five largest patented crop chemical companies and will continue to develop new products, with a focus on biologicals, through its research and development pipeline.

Read more on FMC